Clinical Trial Update: Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy and safety of the HRS9531 injection in adults with obesity without diabetes and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• HRS9531

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Overweight or Obesity | Phase 2 | Status: COMPLETED